The Value of Rapid Antigen Tests to Identify Carriers of Viable SARS-CoV-2 Antigenic tests to identify patients with viable SARS-CoV-2

18 The search for effective methods to detect patients who excrete a viable virus is 19 one of the urgent tasks of modern biomedicine. In the present study, we examined the 20 diagnostic value of two antigen tests BIOCREDIT COVID-19 Ag (RapiGEN Inc., Korea) 21 and SGTI-flex COVID-19 Ag (Sugentech Inc., Korea) for their diagnostic value in 22 identifying patients who excrete viable SARS-CoV-2. As part of the study, we examined 23 samples from 106 patients who had just been admitted to the hospital, who had 24 undergone quantitative RT-PCR and assessment of viability of SARS-CoV-2 using cell 25 culture. Sensitivity was 0.786 (0.492–0.953)


Introduction
for the spread of the virus and for accounting for COVID-19 cases [5]. 48 The recent successful launch of SARS-CoV-2 vaccines gives hope for an early 49 reduction of the pandemic and a return to pre-quarantine living conditions [6], [7], [8], 50 [9]. All major vaccines ensure a convincing level of protection (over 90%) in the short 51 term and reliable protection against the severe course of COVID-19. At the same time,

90
Study design 91 To investigate the ability of rapid antigen tests to identify patients who excrete 92 viable SARS-CoV-2, it was planned to include primarily patients with suspected COVID- 93 19 newly admitted to the hospital. Participants were admitted to the hospital on 2 to 10 94 days from the onset of symptoms. The main symptoms were fever, dry cough, chest 95 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)  is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.10.21252667 doi: medRxiv preprint with further increase in viral load. 120 To determine the analytical threshold of sensitivity with respect to the antigen in 121 virions of the culture fluid, we conducted a model experiment, when the culture fluid with 122 a known virus titer was used to assess the analytical sensitivity of rapid tests in the 123 range from 10 2 to 10 8 GE/mL, using an interval of one order of magnitude. Both tests 124 showed the detection limit at a virus titer of 10 6 GE/mL (10 5 GE/test), which 125 corresponded to 4×10 5 TCID50/mL or 4×10 4 TCID50/test. There was no statistically 126 significant difference in analytical characteristics depending on the day from the onset of 127 the disease (p-value = 0.2356 for SGTI-flex COVID-19 Ag, p-value = 0.8581 for 128 RapiGen Biocredit COVID-19 Ag with Fisher's exact test), which is not surprising given 129 that there were high-load patients on each day (Appendix Table 3). 138 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted March 12, 2021. ; https://doi.org/10.1101/2021.03.10.21252667 doi: medRxiv preprint  Table 2). However, not all samples with such a load remained viable. 144 Rapid tests were able to give a positive result on samples with median values of 145 5.72×10 4 and 3.78×10 4 (GE/mL) for Biocredit COVID-19 Ag and SGTI-flex COVID-19 146 Ag, respectively. However, a positive result was also obtained for a number of samples 147 with a load below 10 4 (GE/mL). It is not clear whether this is related to how the material 148 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted March 12, 2021.  (Table 3)  is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.  226 We examined samples from 106 patients admitted to a hospital in Moscow. The 227 study included only those patients who had experienced first symptoms no earlier than 228 10 days before. All samples, in addition to being used for the two tests, were also used 229 for quantitative PCR and assessment of viral viability using cell culture. Of 106 samples, 230 78 (73.58%) were PCR-positive. This is significantly higher than previously published 231 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted March 12, 2021.  1.519e-08 for Biocredit COVID-19 Ag). This means that rapid tests have significantly 258 better results for the task of identifying viable SARS-CoV-2. 259 We are not aware of any other studies that analyze the value of antigen tests to 260 identify patients who excrete viable virus. Results obtained in this study require 261 confirmation using more samples from patients who excrete viable virus. In this study, 262 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)  310 All collected samples were tested immediately after transportation. PCR amplification 311 was carried out using a one-step "SARS-CoV-2 FRT" commercial kit with catalog 312 number ЕА-128 (bought from N.F. Gamaleya NRCEM, Moscow, Russia). According to 313 manufacturer's information "SARS-CoV-2 FRT" kit allows to amplify a fragment from the 314 5' end region encoding the NSP1 gene (aprox. 450 to 650 nt bases upstream the 5' end 315 of SARS-CoV-2 viral genome). The protocol for qPCR-RT used in this study had been 316 described previously [29]. Briefly the conditions of the one-step RT-qPCR reaction were 317 as follows: 50°C for 15 min, 95°C for 5 min, followed by 45 cycles of 95°C for 10 s and 318 55°C for 1 min. The number of copies of viral RNA was calculated using a standard 319 curve generated by amplification of plasmid cloned DNA template fragment encoding 320 450 to 650 nt bases upstream the 5' end of SARS-CoV-2 viral genome. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)